PASG
#4724
Passage Bio, Inc. - Common Stock
4.4 6 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.41%
Monthly Change
-21.62%
6 month change
-49.55%
Year Change
-49.55%
Previous Close
4.5 7
Open
4.4 6
Low
4.4 6
High
4.4 6
Volume
3
Financials
- Market Capitalization 14.31 M
- Employee 24
- Founded 2017
- CEO N/A
- Website www.passagebio.com
- Headquarter Delaware, United States
- FIGI BBG00NBK4XF9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.82
Price to sales ratio
25.52
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4720 |  LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | -9.23% | +5.36% | -1.67% | -29.76% | 14.62 M USD | ||
| 4722 |  TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | +1.03% | -8.41% | -24.03% | -59.00% | 14.51 M USD | ||
| 4729 |  GTBP GT Biopharma, Inc. - Common Stock | 0.39 USD | -9.30% | -17.02% | -18.75% | -81.78% | 14.06 M USD | ||
| 4730 |  QNCX Quince Therapeutics, Inc. - Common Stock | 17.25 USD | -1.65% | +2.19% | +1754.84% | +853.04% | 14.06 M USD |
Frequently asked questions about Passage Bio, Inc. - Common Stock
What is the Passage Bio, Inc. - Common Stock stock price today?
The current price of Passage Bio, Inc. - Common Stock (PASG) is 4.46. Over the past 24 hours, the stock has changed by -2.41%. Follow the PASG chart for real-time price dynamics.
What is the stock ticker of Passage Bio, Inc. - Common Stock?
Passage Bio, Inc. - Common Stock trades under the ticker PASG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Passage Bio, Inc. - Common Stock stock going up?
PASG has changed by -4.50% over the last week, -21.62% over the last month, and -49.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Passage Bio, Inc. - Common Stock net income for the last quarter?
Passage Bio, Inc. - Common Stock reported net income of -7.56 M for the last quarter. The previous quarter showed -12.98 M, which means net income changed by +41.78%.
How many employees does Passage Bio, Inc. - Common Stock have?
As of the latest available data, Passage Bio, Inc. - Common Stock has 24 employees. Workforce size can provide additional context about the company's scale and operations.
What is Passage Bio, Inc. - Common Stock EBITDA?
Passage Bio, Inc. - Common Stock EBITDA is -4.3 M, and its EBITDA margin is -1 208.43%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Passage Bio, Inc. - Common Stock stock?
You can buy Passage Bio, Inc. - Common Stock (PASG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Passage Bio, Inc. - Common Stock stock?
Investing in Passage Bio, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PASG chart and related analysis on metatrader.com as part of your research.